Ngā kupu hautoa kōpae
Tohutoro APA (7th ed.)
Digomann, D., Heiduk, M., Reiche, C., Glück, J., Kahlert, C., Mirtschink, P., . . . Seifert, A. M. (2023). Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer. Nature Portfolio.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Tohutoru Kātū Chicago (17th ed.)
Digomann, David, et al. Serum Immune Checkpoint Profiling Identifies Soluble CD40 as a Biomarker for Pancreatic Cancer. Nature Portfolio, 2023.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Tohutoro MLA (9th ed.)
Digomann, David, et al. Serum Immune Checkpoint Profiling Identifies Soluble CD40 as a Biomarker for Pancreatic Cancer. Nature Portfolio, 2023.
I tāruatia paitia ki te papatopenga
Kua rahua te tārua ki te papatopenga
Kia tūpato: Kāore pea ēnei kupu hautoa i te ōrite pū 100%.